Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Join
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Join
FREE
Allergy & Immunology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Ultra-Processed Foods and Their Impact on Allergies and Health
April 2025
While food additives play a crucial role in food preservation and enhancement, their potential long-term effects on immune and metabolic health remain a growing concern.
Read more
25 Nov 2024
Undiagnosed Asthma Widespread Among Sub-Saharan Adolescents
Between 1990–2010, the number of African children with asthma rose from 34 million to 50 million, driven partly by increased urbanisation.
23 Nov 2024
Rare Gene Variant Protects against Type 2 Asthma
This variant results in reduced STAT6 protein levels, dampened IL-4 responses, and lower IgE and eosinophil counts in the blood.
21 Nov 2024
B-Cell Depletion Reduces IgG4 Disease Flare Risk
The trial included 135 adults, randomly assigned to receive either inebilizumab or a placebo for a 52-week treatment period.
19 Nov 2024
Low-Dose IL-2 Shows Promise for Allergic Rhinitis Relief
In the trial, patients received either IL-2 (1 MUI/day) or a placebo for 5 days, followed by weekly doses for 4 weeks.
17 Nov 2024
AI Models to Personalise Immune Therapies for Patients with Cancer
The study aims to customise CIC profiles for patients, providing insights into which stages of the cycle are most relevant for tailored cancer therapies and diagnostics.
16 Nov 2024
Early RSV Vaccination in Pregnancy Enhances Neonatal Protection
he study aimed to evaluate how gestational age at the time of vaccination and the time elapsed until delivery impacted antibody levels in the newborn.
13 Nov 2024
Breakthrough in COVID-19 Care: Nasal Autoantibodies Offer Clues for Personalised Treatment
Groundbreaking research from Emory University has revealed that autoantibodies found in the nasal cavity may provide a critical defence against severe COVID-19 symptoms.
11 Nov 2024
Achieving Equity in Food Allergy Immunotherapy Trials
A recent review reveals significant racial and ethnic disparities in FOIT clinical trials.
Loading posts...
« Previous
1
…
6
7
8
9
10
…
26
Next »